Skip to content

impact of Indoxyl Sulfate on prognosis following PCI in patients with CKD

impact of Indoxyl Sulfate on prognosis following PCI in patients with CKD - IS-PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009501
Enrollment
30
Registered
2012-12-07
Start date
2012-12-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

None listed

Sponsors

Mitsui Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients on chronic kidney disease (eGFR<60) who under go PCI 2) Patient who give informed consent

Exclusion criteria

Exclusion criteria: Patients whom investigater/phisicians consider to be inappropriat to participae in the study

Design outcomes

Primary

MeasureTime frame
cardiovasculr event at one year

Countries

Japan

Contacts

Public ContactKengo Tanabe

Mitsui Memorial Hospital Division of Cardiology

kengo-t@zd5.so-net.ne.jp03-3862-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026